These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 3620698
1. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Packham MA, Kinlough-Rathbone RL, Mustard JF. Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698 [Abstract] [Full Text] [Related]
2. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
4. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R, Mezzasoma AM, Venditti G, Gresele P. Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [Abstract] [Full Text] [Related]
5. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM, Wu TS, Teng CM. Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [Abstract] [Full Text] [Related]
6. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
7. Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. Harfenist EJ, Packham MA, Kinlough-Rathbone RL, Cattaneo M, Mustard JF. Blood; 1987 Sep 01; 70(3):827-31. PubMed ID: 3497679 [Abstract] [Full Text] [Related]
9. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R, Nenci GG, Gresele P. J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1497-505. PubMed ID: 8531121 [Abstract] [Full Text] [Related]
12. Effect of calcium concentration and inhibitors on the responses of platelets stimulated with collagen: contrast between human and rabbit platelets. Packham MA, Rand ML, Ruben DH, Kinlough-Rathbone RL. Comp Biochem Physiol A Comp Physiol; 1991 Dec 01; 99(4):551-7. PubMed ID: 1679691 [Abstract] [Full Text] [Related]
16. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Packham MA, Bryant NL, Guccione MA, Kinlough-Rathbone RL, Mustard JF. Thromb Haemost; 1989 Nov 24; 62(3):968-76. PubMed ID: 2512683 [Abstract] [Full Text] [Related]
19. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets. de Chaffoy de Courcelles D, De Clerck F. Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257 [Abstract] [Full Text] [Related]
20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J. Thromb Haemost; 1998 Jun 13; 79(6):1184-90. PubMed ID: 9657446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]